Učitavanje...
Rational study endpoints in anti-neoplastic agent regulatory approval trials in the gynecologic malignancies
A discussion of rational endpoints in clinical trials seeking regulatory approval for new anti-neoplastic agents involving the three major gynecologic malignancies, cancers of the ovary, cervix, and endometrial, is particularly interesting as (in the opinion of this commentator) the conclusion will...
Spremljeno u:
| Izdano u: | Womens Health (Lond) |
|---|---|
| Glavni autor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5373277/ https://ncbi.nlm.nih.gov/pubmed/27638892 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1745505716655555 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|